Baker McKenzie acted as legal adviser to the Joint Bookrunners in connection with the transaction and Vinge advised Xspray Pharma.
Xspray Pharma AB completed a private placement of shares through an accelerated book building procedure, raising approximately SEK 265 million before transaction costs.
Xspray Pharma is a product development company with multiple product candidates in clinical development.
Citigroup Global Markets Limited, Pareto Securities and Zonda Partners acted as Joint Bookrunners.
The Baker McKenzie team consisted of Henric Roth (Picture) and Joakim Falkner.
Vinge’s team has consisted of Dain Hård Nevonen, Linnéa Sellström, Joel Magnusson and Linnea Petersson.